Genotyping of C.elegans mutants - CRISPR/Cas9 of all GPCR and neuropeptide genes
CRISPR/Cas9 genome editing was used to disrupt nearly all the GPCR and neuropeptide genes from C. elegans genome. Multiple genes were disrupted in each strain for the purpose of screening. The genotype is the list of targeted genes